
Prescription Drug Name:
Sodium Sulfacetamide 10% Sulfur 2% Cream
ID:
620baf55-495a-b099-e053-2a91aa0a8566
Code:
34391-3
DESCRIPTION:
id: 620baf55-495c-b099-e053-2a91aa0a8566
displayName: DESCRIPTION SECTION
FDA Article Code: 34089-3
in a base containing BHT, Ceteareth-20, Cetearyl Alcohol, Cetyl Alcohol,Disodium EDTA, Ethylhexyl Palmitate, Ethylparaben, Fragrance, Glyceryl Monostearate SE, Methylparaben, Phenoxyethanol, Propylene Glycol, Propylparaben, Purified Water, Sodium Thiosulfate and Xanthan Gum.
CLINICAL PHARMACOLOGY:
id: 620baf55-495d-b099-e053-2a91aa0a8566
displayName: CLINICAL PHARMACOLOGY SECTION
FDA Article Code: 34090-1
bacterial growth by acting as a competitive antagonist of para-aminobenzoic acid (PABA). While absorption
through intact skin has not been determined for sodium sulfacetamide, it is estimated that 1% of topically applied
sulfur is absorbed. Although the exact mode of the keralytic activity of sulfur is unknown, it is reported to result
from the interaction of sulfur with the cysteine content of keratinocytes. In combination with sulfacetamide, sulfur
has been reported to inhibit
INDICATIONS:
id: 620baf55-495e-b099-e053-2a91aa0a8566
displayName: INDICATIONS & USAGE SECTION
FDA Article Code: 34067-9
rosacea and seborrheic dermatitis.
CONTRAINDICATIONS:
id: 620baf55-495f-b099-e053-2a91aa0a8566
displayName: CONTRAINDICATIONS SECTION
FDA Article Code: 34070-3
hypersensitivity to sulfonamides, sulfur or any other component of this preparation. Sodium Sulfacetamide 10% Sulfur 2%
Cream is not to be used by patients with kidney disease.
WARNINGS:
id: 620baf55-4960-b099-e053-2a91aa0a8566
displayName: WARNINGS SECTION
FDA Article Code: 34071-1
supervision should be observed when prescribing this drug for patients who may be prone to hypersensitivity to
topical sulfonamides. Systemic toxic reactions such as agranulocytosis, acute hemolytic anemia, purpura
hemorrhagica, drug fever, jaundice and contact dermatitis indicate hypersensitivity to sulfonamides. Particular
caution should be employed if areas of denuded or abraded skin are involved.
ADVERSE REACTIONS:
id: 620baf55-4968-b099-e053-2a91aa0a8566
displayName: ADVERSE REACTIONS SECTION
FDA Article Code: 34084-4
DOSAGE AND ADMINISTRATION:
id: 620baf55-4969-b099-e053-2a91aa0a8566
displayName: DOSAGE & ADMINISTRATION SECTION
FDA Article Code: 34068-7
HOW SUPPLIED:
id: 620baf55-496a-b099-e053-2a91aa0a8566
displayName: HOW SUPPLIED SECTION
FDA Article Code: 34069-5
PRINCIPAL DISPLAY PANEL – 57 g Tube Label
id: 620baf55-496e-b099-e053-2a91aa0a8566
displayName: PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
FDA Article Code: 51945-4
Sulfur 2% Cream
PHARMACEUTICALS, LLC